Keywords: زیر جلدی; Surgical site infections; Prophylaxis; Cefazolin; Subcutaneous; Pharmacokinetics;
مقالات ISI زیر جلدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زیر جلدی; 5HT; 5-hydroxytryptamine (serotonin); AUC; Area-Under-the-Curve; bPNS; bilateral pudendal nerve stimulation; GABA; gamma amino butyric acid; IC/BPS; interstitial cystitis/bladder pain syndrome; i.v.; intravenous; s.c.; subcutaneous; T; stimulation intensi
Keywords: زیر جلدی; ERA; endothelin receptor antagonist; IPAH; idiopathic pulmonary arterial hypertension; PAH; pulmonary arterial hypertension; PDE; phosphodiesterase; SC; subcutaneous; 6MWT; 6-minute walk test; Subcutaneous prostanoid; Pediatric treatment; Pulmonary hypert
Keywords: زیر جلدی; Subcutaneous; Hydatid cyst; Unusual site; Right hypochondrium; Primary; Isolated;
Keywords: زیر جلدی; Insulin; Injection; Diabetes; Needle length; Safety pens; Injection technique; Long-term care; Long-term care residents; Hypoglycemia; Subcutaneous; Intramuscular; Site rotation; Absorption rate;
Keywords: زیر جلدی; Anticoagulants; Cryotherapy; Hematoma; Injections; Subcutaneous; Pain;
Keywords: زیر جلدی; diuresis; furosemide; heart failure; pharmacokinetics; subcutaneous; ANOVA; analysis of variance; AUC; area under the curve; AUCâ; plasma concentration to infinity; AUClast; last measurable plasma concentration; CI; confidence interval; Cmax; peak plasm
Keywords: زیر جلدی; Urticaria; Biomarkers; CRP; IL-6; MPV; D-dimer; F1+2; Biologics; Omalizumab; ASCENT-I; ASCENT-II; GLACIAL; IL-1 antagonists; TNF-α inhibitors; Intravenous immunoglobulin; Rituximab; Ligelizumab; Quilizumab; ASST; Autologous serum skin test; ATA; Antithyr
Keywords: زیر جلدی; aCSF; artificial cerebrospinal fluid; AICAR; 5-aminoimidazole-4-carboxamide-riboside; AMPK; 5â² adenosine monophosphate-activated protein kinase; ARH; arcuate hypothalamic nucleus; AVPV; anteroventral periventricular nucleus; CRH; corticotropin-releasing
Keywords: زیر جلدی; Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: زیر جلدی; bid; twice daily; CNHSQ; Children's National Health System Questionnaire; EPO; erythropoietin; FeSo4; ferrous sulfate 300 mg tid; IM; intramuscular; IV; intravenous; LAR; long-acting release; NA; not available; OD; once daily; OHQ; Orthostatic Hypotension
Keywords: زیر جلدی; Severe asthma; Anti-IL-5; mAb; Continuation; Response; ACQ-5; 5-item Asthma Control Questionnaire; IV; Intravenous; PARR; Placebo-adjusted rate ratio; RR; Rate ratio; RRNC; Rate ratio for noncontinuers; SC; Subcutaneous;
Keywords: زیر جلدی; biomarkers; catheterizations; pulmonary arterial hypertension; 6MWD; 6-min walk distance; BNP; brain natriuretic peptide; CHD; congenital heart disease; CTD; connective tissue disease; ESC/ERS; European Society of Cardiology/European Respiratory Society;
Keywords: زیر جلدی; SC; subcutaneous; OA-NO2; nitro oleic acid; ACD; allergic contact dermatitis; CHS; contact hypersensitivity; LNO2; nitro linoleic acid; CLA-NO2; conjugated nitro linoleic acid; PPAR-γ; peroxisome proliferator-activated receptor-γ; Nrf2; nuclear factor E
Keywords: زیر جلدی; Lymphatic; Biologic; Therapeutic proteins; Pharmacokinetics; Biodistribution; Intravenous; Trastuzumab; Interferon; Pegylated interferon; IFN-PEG40; 60 kDa Pegylated interferon α2a, PEGASYS®; IFN-PEG12;  ~ 31 kDa Pegylated interferon α2b, PEG-Intro
Keywords: زیر جلدی; GLP-1; GLP-1 receptor agonists; Energy expenditure; Systematic review; AIEE; activity-induced energy expenditure; BM; body mass; BW; body weight; CHF; chronic heart failure; CHO; carbohydrate; CI; confidence interval; DIT; diet-induced thermogenesis; EE;
Keywords: زیر جلدی; BSA; bovine serum albumin; CGRP; calcitonin gene-related peptide; DPA; dynamic plantar aesthesiometer; FPKM; fragments per kilobase of exon per million reads mapped; GFAP; glial fibrillary acidic protein; GO; gene ontology; i.p.; intraperitoneal; Iba1; io
Keywords: زیر جلدی; Lyotropic liquid crystalline preconcentrates; Liquid crystalline phases; Sustained release; Phase transition; In situ gel; Artemisinin based combination therapy (ACT); ACT; artemisinin-based combination therapy; LUM; lumefantrine; LLCPr; lyotropic liquid
Keywords: زیر جلدی; phospholipids; liposomes; apoptosis; immune response; proteins; biotechnology; HA; Hemophilia A; FVIII; factor VIII; GAA; acid alpha glucosidase; rhGAA; recombinant human GAA; PS; phosphatidylserine; TIM-4; T-cell immunoglobulin and mucin 4; MOG; myelin o
Keywords: زیر جلدی; ADME; absorption distribution metabolism elimination; ASEs; aerosols solvent extractions; AUC; area under curve; BBB; blood-brain barrier; BCS; Biopharmaceutical Classification System; BDP; beclomethasone dipropionate; CFC; critical flocculation concent
Keywords: زیر جلدی; Polymer film patch; Polyvinyl alcohol; PVA; Intradermal delivery; Skin ablation; Micropore; Er:YAG laser; Skin vaccination; Transcutaneous immunization; APC; antigen-presenting cell; BCA; bicinchoninic acid; CD; cluster of differentiation; CMC; carboxymet
Keywords: زیر جلدی; UNITI Trials; Inflammatory Bowel Disease Treatment; IBD; Anti-IL12/23; 6-MP; 6-mercaptopurine; AUC; area under the curve; AZA; azathioprine; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; Creactive protein; ECLIA; electrochemilumines
Keywords: زیر جلدی; Medicinal plants; North Eastern region; Morocco; Toxic plants; Alkaloids; AT; acute toxicity; ATR; atractyloside; C; cultivated; CA; cutaneous application; CATR; carboxyatractyloside; CBCH; cannabichromene; CBD; cannabidiol; CBN; cannabinol; CT; chronic t
Keywords: زیر جلدی; Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: زیر جلدی; robustness; quality by design; biopharmaceutical; drug product; formulation; manufacturing process; design space; BLA; biological license application; BPDG-FPS; Biophorum Development Group-Formulation Point Share; CQA; critical quality attribute; CPP; c
Keywords: زیر جلدی; 2-AG; 2-arachidonoyl glycerol; 11-nor-THC-COOH; 11-nor-tetrahydrocannabinol-9-caboxylic acid; 11-OH-THC; 11-hydroxy-tetrahydrocannabinol; 8-OH-THC; 8-hydroxy-tetrahydrocannabinol; CB; cannabinoid; CB1R; Type I cannabinoid receptor; CB2R; Type II cannabino
Keywords: زیر جلدی; BMI; Body Mass Index; CRF; Clinical Report Form; FIT; Forum for Injection Technique; FITTER; Forum for Injection Technique and Therapy: Expert Recommendations; GCP; Good Clinical Practice; HbA1c; Glycated hemoglobin; IM; Intramuscular; ITQ; Injection Tech
Keywords: زیر جلدی; DM; diabetes mellitus; BW; body weight; ADI; acceptable daily intake; OGTT; oral glucose tolerance test; SC; subcutaneous; IP; intraperitoneal; SD; standard deviation; Diabetes mellitus; Stevioside; Stevia rebaudiana;
Keywords: زیر جلدی; Cadaver model; subcutaneous; submuscular; transposition; ulnar nerve repair;
Keywords: زیر جلدی; AVF; arteriovenous fistula; BVT; basilic vein transposition; KDOQI; Kidney Disease Outcome Quality Initiative; s.c.; subcutaneous; US; ultrasonography; Basilic vein; Brachial artery; Minimally invasive; Fistula; Transposition;
Keywords: زیر جلدی; Kg; kilogram; I.P.; intra-peritoneal; MEMRI; manganese-enhanced MRI; Mg; milligram; MnCl2; manganese chloride; S.C.; subcutaneous; MEMRI; Manganese MRI; Side effects; Manganese toxicity; Longitudinal monitoring;
Keywords: زیر جلدی; BBB; Basso-Beattie-Bresnahan (locomotor recovery scale); CNS; central nervous system; dpi; days post-injury; s.c.; subcutaneous; SCI; spinal cord injury; SUDO; simplified up-down; T-; thoracic segment; Central nervous system; Neuropathic pain; Nervous sys
Keywords: زیر جلدی; DOP; δ opioid receptor; EM-1; endomorphin-1; EM-2; endomorphin-2; i.c.v.; intracerebroventricular; i.p.; intraperitoneal; i.t.; intrathecal; KOP; κ opioid receptor; MOP; μ opioid receptor; MPE; maximum possible effect; s.c.; subcutaneous; Spinal antino
Keywords: زیر جلدی; Adipose tissue; Extracellular matrix; Intramuscular; Korean cattle; Omental; Subcutaneous;
Keywords: زیر جلدی; Arg1; Arginase-1; BDNF; brain derived neurotrophic factor; Fizz1; found in inflammatory zone 1; IGF; insulin-like growth factor; IL; interleukin; IL-1ra; IL-1 receptor antagonist; LPS; lipopolysaccharide; PBS; phosphate-buffered saline; RT-PCR; real-time
Keywords: زیر جلدی; CBC; Complete blood count; EMA; European Medicines Agency; FDA; US Food and Drug Administration; IL; Interleukin; JIA; Juvenile idiopathic arthritis; LFT; Liver function testing; MAS; Macrophage activation syndrome; SLE; Systemic lupus erythematosus; SQ;
Keywords: زیر جلدی; bioavailability; hydroxyprogesterone caproate; pharmacokinetic properties; route of administration; subcutaneous;
Keywords: زیر جلدی; Hereditary angioedema; Bradykinin; C1 inhibitor deficiency; Bradykinin B2 receptor antagonist; Icatibant; Children; Adolescents; Pediatrics; Treatment; AE; adverse event; C1-INH; C1 inhibitor; C1-INH-HAE; hereditary angioedema with C1-inhibitor deficiency
Keywords: زیر جلدی; Subcutaneous; Fat; Ultrasound; Maternal; Adipose tissue;
Keywords: زیر جلدی; BDS; bulk drug substance; BPL; β-propiolactone; cGMP; current good manufacturing practices; DENV; dengue virus; DP; drug product; Env; envelope protein; FFA; focus forming assay; GLP; good laboratory practices; H2O2; hydrogen peroxide; IVRP; in vitro rel
Keywords: زیر جلدی; Adjuvant; Breast cancer; HER2/neu; Herceptin; Subcutaneous; Trastuzumab;
Keywords: زیر جلدی; Antiasthmatic agents; exacerbation; emergency service; hospital; IL-5; mepolizumab; severe eosinophilic asthma; meta-analysis; IV; Intravenous; OCS; Oral corticosteroid; SC; Subcutaneous;
Keywords: زیر جلدی; Sweet syndrome; Leukemia; Subcutaneous; Genetic; Chemotherapy;
Keywords: زیر جلدی; BMD; bone mineral density; BSAP; bone-specific alkaline phosphatase; CI; confidence interval; CTX; C-telopeptide of type 1 collagen; DXA; dual-energy x-ray absorptiometry; LS mean; least squares mean; P1NP; procollagen type 1Â N-terminal propeptide; Q1; f
Keywords: زیر جلدی; Ketamine; depression; randomized controlled trial; geriatric; subcutaneous; dose;
Keywords: زیر جلدی; CIT; citalopram; FST; forced swim test; MDD; major depressive disorder; Pre; pre-incubation; Post; post-incubation; s.c.; subcutaneous; Tb; body temperature; Trec; rectal temperature; TRPv4; transient receptor potential cation channel subfamily V member 4
Keywords: زیر جلدی; Nausea; Vomiting; Fullness; Bloating; b.i.d; twice daily; DGSSD; Diabetic Gastroparesis Symptom Severity Diary; FDA; US Food and Drug Administration; GCSI-DD; Gastroparesis Cardinal Symptom Index-Daily Diary; GEBT; gastric emptying breath test; PRO; patie
Keywords: زیر جلدی; 1,5-AG; 1,5-anhydroglucitol; AUC; area under curve; CGM; Continuous Glucose Monitoring; CI; confidence interval; CONGAn; Continuous Overlapping Net Glycemic Action; CV; Coefficient of Variance; DCCT; Diabetes Control and Complication Trial; FPG; fasting p
Keywords: زیر جلدی; Morphine; Dosing regimen; Antinociceptive tolerance; Antinociception; MPE; maximum possible effect; s.c.; subcutaneous; b.i.d.; two times daily;
Keywords: زیر جلدی; Proinsulin; Therapy; Adeno-associated virus vector; Cognitive loss; Inflammaging; A2M; α-2-macroglobulin; Aβ; amyloid β peptides; AβPP; amyloid β protein precursor; AAV; adeno-associated virus; AD; Alzheimer's disease; Akt; protein kinase B; ANOVA; a